Evidence map›Paper›PMID 26310270›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.

Qing Wu, Jiaojiao Zhang, Wonshill Koh, Qingming Yu, Xiaojun Zhu, Adam Amsterdam, George E Davis, M Amin Arnaout, Jing-Wei Xiong

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. FLI1 and GATA1 governHaematologica · 2025
    Article
  4. Review
  5. Zebrafish (International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Mechanisms of FA-Phagy, a New Form of Selective Autophagy/Organellophagy.Frontiers in cell and developmental biology · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Qing Wu*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jiaojiao Zhang*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Wonshill Koh*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Qingming Yu*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Xiaojun Zhu*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Adam Amsterdam*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
George E Davis*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
M Amin Arnaout*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jing-Wei Xiong*Beijing Key Laboratory of Cardiometabolic Molecular Medicine and State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Peking University, Beijing, China; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Pharmacology and Department of Physiology, School of Medicine, University of Missouri, Columbia, Missouri, USA; and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA jingwei_xiong@pku.edu.cn.
Peking University · CNMassachusetts General Hospital · USUniversity of Missouri · USHarvard University · USMassachusetts Institute of Technology · US

Funding

TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
Structure and Function of beta2 IntegrinR01DK048549 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 1994 to 2016
$6.0M
Structure and Function of Integrins in the KidneyR01DK088327 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2010 to 2025
$5.3M
INSERTIONAL MUTAGENESIS SCREENR01RR012589 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HOPKINS, NANCY H. · 1998 to 2005
$5.0M
GENES REGULATING CAPILLARY MORPHOGENESIS AND APOPTOSISR01HL059373 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DAVIS, GEORGE E · 1998 to 2011
$3.3M
Pathogenesis of ADPKD-role of the transcriptional modulator TAZR01DK075999 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2007 to 2010
$1.1M
NCRR NIH HHS R01 RR012589NCRR NIH HHS RR012589NHLBI NIH HHS HL59373NHLBI NIH HHS R01 HL059373NIDDK NIH HHS DK088327NIDDK NIH HHS DK48549NIDDK NIH HHS R01 DK048549NIDDK NIH HHS R01 DK075999NIDDK NIH HHS R01 DK088327NIDDK NIH HHS T32 DK007540NIDDK NIH HHS T32-DK07540
6 · The paper itself

Abstract

Talin (tln) binds and activates integrins to couple extracellular matrix-bound integrins to the cytoskeleton; however, its role in heart development is not well characterized. We identified the defective gene and the resulting cardiovascular phenotypes in zebrafish tln1(fl02k) mutants. The ethylnitrosourea-induced fl02k mutant showed heart failure, brain hemorrhage, and diminished cardiac and vessel lumens at 52 h post fertilization. Positional cloning revealed a nonsense mutation of tln1 in this mutant. tln1, but neither tln2 nor -2a, was dominantly expressed in the heart and vessels. Unlike tln1 and -2 in the mouse heart, the unique tln1 expression in the heart enabled us, for the first time, to determine the critical roles of Tln1 in the maintenance of cardiac sarcomeric Z-disks and endothelial/endocardial cell integrity, partly through regulating F-actin networks in zebrafish. The similar expression profiles of tln1 and integrin β1b (itgb1b) and synergistic function of the 2 genes revealed that itgb1b is a potential partner for tln1 in the stabilization of cardiac Z-disks and vessel lumens. Taken together, the results of this work suggest that Tln1-mediated Itgβ1b plays a crucial role in maintaining cardiac sarcomeric Z-disks and endothelial/endocardial cell integrity in zebrafish and may also help to gain molecular insights into congenital heart diseases.

Indexed as

Amino Acid SequenceAnimalsEndothelium, VascularHeartHumansHuman Umbilical Vein Endothelial CellsIntegrin beta1MiceMolecular Sequence DataMutationSequence Homology, Amino AcidTalinZebrafishIntegrin beta1Talincardiac sarcomerecardiovascular developmentitgb1btln1

Identifiers

PMID26310270
PMCPMC4653057
OpenAlexW1151031465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.